Candidate list of yoUr biomarker (CLUB): A web-based platform to aid cancer biomarker research

Biomarker Insights

Volumn 2008, Issue 3, 2008, Pages 65-71

  Lee, Bernett T K ^a   Liew, Lailing ^a   Lim, Jiahao ^a   Tan, Jonathan K L ^a   Lee, Tze Chuen ^a   Veladandi, Pardha S ^a   Lim, Yun Ping ^a   Han, Hao ^a   Rajagopal, Gunaretnam ^a   Anderson, N Leigh ^b  

^a BIOINFORMATICS INSTITUTE   (Singapore)

^b The Plasma Proteome Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; BIOMOLECULAR INTERACTION NETWORK DATABASE; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANDIDATE LIST OF YOUR BIOMARKER DATABASE; COMPUTER INTERFACE; CONTROLLED STUDY; FACTUAL DATABASE; GENE ONTOLOGY DATABASE; HUMAN; INTACT INTERACTION DATABASE; INTERNET; MEDICAL LITERATURE; MOLECULAR INTERACTION; OUTCOME ASSESSMENT; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; PUBLICATION; REFERENCE DATABASE; SWISS-PROT; VALIDATION PROCESS;

EID: 39549099714     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s467     Document Type: Article

References (19)

1. Aebersold, R., Anderson, L. and Caprioli, R. et al. 2005. Perspective: a program to improve protein biomarker discovery for cancer. J. Proteome. Res. 4:1104-9.
2. Anderson, N.L. and Anderson, N.G. 2002. The human plasma proteome: history, character and diagnostic prospects, Mol. Cell. Proteomics 1:845-67.
3. Ashburner, M., Ball, C.A. and Blake, J.A. et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25:2-5-9.
4. Bader, G.D., Betel, D. and Hogue, C.W. 2003. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res., 31-248-50.
5. Baggerly, K.A., Morris, J.S. and Edmonson, S.R. et al. 2005. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst., 97:307-9.
6. Bairoch, A., Apweiler, R. 1997. The SWISS-PROT protein sequence database: its relevance to human molecular medical research. J. Mol. Med., 75, 312-6.
7. Bullinger, L., Dohner, K. and Bair, E. et al. 2004. Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia. N. Engl. J. Med., 350:1605-16.
8. Cho, W.C. 2007. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer, 6:25.
9. Efroni, S., Schaefer, C.F. and Buetow, K.H. 2007. Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS ONE, 2:e425.
10. Dahlquist, K.D., Salomonis, N. and Vranizan, K. et al. 2002. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet., 31:19-20.
11. Diamandis, E.P. 2004. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J. Natl. Cancer Inst., 96, 353-6.
12. Feng, W., Wu, B. and Phan, J. et al. 2005. An integrated cancer biomarket information system. Conf. Proc. IEEE Eng. Med. Biol. Soc., 3:2851-54.
13. Gulmann, C., Sheehan, K.M. and Kay, E.W. et al. 2006. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics and therapy guidance in cancer. J. Pathol., 208:595-606.
14. Kerrien, S., Alam-Faruque, Y. and Aranda, B. et al. 2007. IntAct - open source resource for molecular interaction data. Nucleic Acids Res., 35:D561-5.
15. Polanski, M. and Anderson, N.L. 2006. A List of Candidate Cancer Biomarkers for Targeted Proteomics. Biomarker Insights, 2:1-48.
16. Pritzker, K. P. 2002. Cancer biomarkers: easier said than done. Clin. Chem., 48:1147-50.
17. Ransohoff, D. F. 2005. Lessons from controversy: ovarian cancer screening and serum proteomics. J. Natl. Cancer Inst., 97:315-9.
18. Zhang, H., Loriaux, P. and Eng, J. et al. 2006. UniPep - a database for human N.-Iinked glycosites: a resource for biomarker discovery. Genome. Biol., 7:R.73.
19. Zhang, Z. and Chan, D.W. 2005. Cancer proteomics: in pursuit of "true" biomarker discovery. Cancer Epidemiol. Biomarkers Prev., 14:2283-86.